Abstract. Antimicrobial sensitivity tests were performed on four-hundred and ninety-seven bacterial isolates from Sudanese patients with diarrhea or urinary tract infections. Shigella dysenteriae type 1 and enteropathogenic Escherichia coli showed high resistance rates (percentage of isolates showing antibiotic resistance) against the commonlyused antimicrobial agents: ampicillin, amoxicillin, chloramphenicol, tetracycline, cotrimoxazole, nalidixic acid, sulfonamide, and neomycin, and were completely sensitive to ciprofloxacin. Eighteen resistance patterns against nine antimicrobial agents tested were observed in enteric pathogens. Resistance to ampicillin, amoxicillin, tetracycline, cotrimoxazole, and sulfonamide was the most frequent pattern. The common urinary pathogens, E. coli, Klebsiella pneumoniae, and Proteus mirabilis showed high rates of resistance to ampicillin, amoxicillin, cotrimoxazole, tetracycline, sulfonamide, trimethoprim, streptomycin, and carbenicillin. We recommend that physicians seek updated knowledge of the common antibiotic-sensitivity patterns when starting empirical antibiotic therapy in Sudanese patients with diarrhea or urinary tract infection.
INTRODUCTION
Resistance to commonly-prescribed antibiotics is an expanding global problem and has been observed in both developed and developing countries. [1] [2] [3] [4] Resistance has emerged even to newer, more-potent antimicrobial agents. 5 A number of epidemics have recently occurred caused by multiply resistant organisms. 6, 7 In the Sudan, bacterial infections of the urinary and gastrointestinal tract are common and represent a frequent cause of morbidity in outpatients as well as a frequent cause of nosocomial infections in many hospitals. Most infections are treated on an empirical basis. Clinical experience has indicated the presence of numerous cases resistant to conventional chemotherapy. Microbial resistance rates to commonly prescribed antibiotics have increased recently. Updated knowledge of the prevailing causal bacteria and their susceptibility patterns is important for the proper selection and use of antimicrobial drugs and for the development of an appropriate prescribing policy.
MATERIALS AND METHODS
One thousand-five-hundred urine samples and one thousand and twenty stool samples were collected from four urban and two rural areas. Both inpatients and outpatients were included in the study. Isolation of enteropathogenic Escherichia coli (EPEC) was limited to patients two-years of age or younger and were cultured from 650 samples. Four-hundred stool samples were cultured for Campylobacter species. Mid-stream urine samples (MSU) were collected from patients five years of age or older. All samples were collected in sterile disposable containers. Stool samples were inoculated into Cary-Blair transport medium.
Stool samples were cultured on deoxycholate citrate agar and McConkey agar, and in selenite-F broth. Identification was confirmed by biochemical tests on API 20 strips (BioMerieux, France). Specific antisera were used to confirm the identification of EPEC, Shigella, and Salmonella (Wellcome Diagnostic, UK). For Campylobacter species a selective medium with Skirrow supplement (Campylobacter medium) was used and the organisms were cultured microaerophilically (Gas packs, Oxoid Inc.) and identified morphologically and by biochemical reactions.
Mid-stream urine samples were cultured on blood agar and McConkey agar using a calibrated standard loop. Isolates from cases with significant bacteruria (Ͼ 10 5 colony/ ml) were identified using API 20 and API Staph strips (BioMerieux, France).
Susceptibility patterns were determined by the Stokes disc-diffusion method 8 performed on diagnostic sensitivity test (DST) agar plates using a rotatory plater. Escherichia coli (NCTC 10418) was used as a control for gram-negative pathogens and Staphylococcus aureus (NCTC 6571) for urinary isolates of staphylococci. Sensitivity to ten antimicrobial agents was determined for all three hundred and sixtytwo urinary pathogens isolated. Of these, one hundred and ten isolates were tested by additional antibiotic discs (Table  1b) .
Isolated urinary organisms were tested against amikacin, cotrimoxazole, ampicillin, amoxicillin, nalidixic acid, nitrofurantoin, cephalexin, gentamicin, sulfonamide, cefuroxime, trimethoprim, tetracycline, streptomycin, ciprofloxacin, carbenicillin, ceftazidime, and chloramphenicol. Isolated enteric pathogens were tested against ampicillin, amoxicillin, chloramphenicol, tetracycline, cotrimoxazole, nalidixic acid, sulfonamide, neomycin, and ciprofIoxacin. In addition to the above, Campylobacter species isolates were tested against erythromycin. Antibiotic concentrations in the diffusion disks are listed in Tables 1a, 1b, and 2. Media and sensitivity discs were obtained from Oxoid Inc., U.K. Tetracycline discs were obtained from Mast Ltd., UK.
Statistical tests of significance were performed using the Student's t-test.
RESULTS
One hundred and fifty-five common pathogenic bacteria were recovered from patients with diarrhea and three-hundred and sixty-two common bacterial organisms were recovered from patients with urinary tract infections (Tables1a, 1b, and 2).
Enteric pathogens. Shigella species were the most com- (100) 10 (100) 9 (90) 10 (100) 10 (100) 2 (20) 9 (90) 10 (100) 10 * Antibiotics used in urinary specimen testing with their respective diffusion-disc concentrations indicated in parentheses: AK ϭ amikcacin (30 g); SX ϭ cotrimoxazole (25 g); AM ϭ ampicillin (25 g); AL ϭ amoxicillin (10 g); NA ϭ nalidixic acid (30 g); F ϭ nitrofurantoin (50 g); CL ϭ cephalexin (30 g); CN ϭ gentamicin (10 g); Su ϭ sulfonamide (500 g); and CX ϭ cefuroxime (30 g). * Antibiotics used in urinary specimen testing with their respective diffusion-disc concentrations indicated in parentheses: T ϭ trimethoprim (2.5 g); Te ϭ tetracycline (10 g); S ϭ streptomycin (25 g); CP ϭ ciprofloxacin (5 g); CR ϭ carbenicillin (100 g); CZ ϭ ceftazidime (30 g); and C ϭ chloramphenicol (10 g). mon pathogens isolated from cases of diarrhea in this study. Sixty-six isolates of Shigella species were identified as follows: Shigella flexneri (59% [39 organisms]) and Shigella dysenteriae type 1 (33% [22 bacteria]). Other Shigella species isolates were considered rare: S. dysenteriae type 2 (3% [2] ), S. dysenteriae of the 3-10 group (2% [1] ) and Shigella sonnei (3% [2] ). Shigella boydii was not isolated in this study. The rate of resistance of the common enteric pathogens is shown in Table 2 . In general, S. flexneri showed a lower resistance rate when compared with S. dysenteriae type 1 except for chloramphenicol (P Ͻ 0.01). No resistance was seen in S. dysenteriae type 1 to ciprofloxacin and nalidixic acid; S. flexneri showed low resistance levels overall (Table 2) .
Salmonella species showed relatively-lower resistance frequency when compared with Shigella flexneri and S. dysenteriae type 1 ( Table 2 )(P Ͻ 0.01). No resistance was detected to chloramphenicol and cotrimoxazole in the eight strains of Salmonella typhi, Salmonella paratyphi A, and Salmonella paratyphi B isolated in this study. These strains were sensitive to all drugs tested except for one S. typhi strain which was resistant to cotrimoxazole, tetracycline, and sulfonamide. One isolated strain of S. paratyphi A was resistant to tetracycline.
Out of eleven Campylobacter species strains, seven showed resistance (63%) to both ampicillin and amoxicillin. All were sensitive to ciprofloxacin. One strain was resistant to erythromycin, chloramphenicol, nalidixic acid, and sulfonamide (Table 2) .
Urinary pathogens. The most common urinary pathogens isolated were E. coIi, Klebsiella pneumoniae, and Proteus mirabilis. Other urinary pathogens were isolated in a relatively few number. Table 1a because of their clinical importance. The percentage resistance of the common urinary and enteric pathogens are shown in Tables 1a, 1b, and 2.
The common urinary pathogens, E. coli, K. pneumoniae, and P. mirabilis showed high resistance when they were tested against ampicillin, amoxicillin, cotrimoxazole, tetracycline, sulfonamide, trimethoprim, streptomycin, and carbenicillin. In comparison, low resistance rates were found against nalidixic acid, cephalexin, and ceftazidime (Tables  1a, 1b) . Escherichia coli showed a relatively low rate of resistance to nitrofurantoin (10% of the isolates) when compared with K. pneumoniae isolates (46%), and P. mirabilis (59%). Only 4% of E. coli isolates were resistant to gentamicin. In contrast, K. pneumoniae and P. mirabilis showed 40% and 37% resistance rates respectively.
Multiple resistance. Eighteen resistance patterns were observed in enteric pathogens for the nine antimicrobial agents tested. Resistance to ampicillin, amoxicillin, tetracycline, cotrimoxazole, sulfonamide (AM-AL-Te-SX-Su) was the most frequent pattern, observed in 73% of the isolates of S. dysenteriae type 1. The most common multiple-resistance pattern was resistance to ampicillin, amoxicillin, tetracycline, cotrimoxazole, sulfonamide, and chloramphenicol (AM-AL-Te-SX-Su-C) ( Table 3 ). This pattern was most frequently observed in S. flexneri (21% of the isolates) and less frequently in Salmonella (13%), S. dysenteriae type 1 (9%), and EPEC (4%). These two patterns were also seen in the two strains of Aeromonas hydrophylia isolated from cases of diarrhea. One strain showed the AM-AL-Te-SX-Su pattern and the other the AM-AL-Te-SX-Su-C pattern.
Multiple resistance was particularly high in urinary pathogens. Escherichia coli had a 58% resistance rate to at least † Erythromycin (15 g) is tested instead of neomycin. NT ϭ neomycin is not tested. four of ten antimicrobial agents (Table 1a) while K. pneumoniae and P. mirabilis had 70% and 82% resistance rates respectively. Escherichia coli (21%), K. pneumoniae (52 %), and P. mirabilis (60%) were resistant to at least five antimicrobial agents. Thirty-three percent of P. mirabilis strains showed multiple resistance rates to at least six antibiotics while K. pneumoniae showed 30%, 13%, 6%, and 2% resistance to 6, 7,8, and 9 drugs respectively.
DISCUSSION
Antimicrobial resistance is now recognized as an increasingly global problem 4 which was observed for the first time in E. coli in 1940. The primary factor responsible for the development and spread of bacterial resistance is the injudicious use of antimicrobial agents. 9 Our study showed a high prevalence of antimicrobial drug resistance in S. dysenteriae type 1 and EPEC isolates ( Table  2) . ShigelIa are the most common organisms in which antibiotic resistance plays an important role in the community and were the first organisms observed to show resistance to multiple drugs. 4 It seems that the prevalence of antibiotic resistance in the Sudan has increased over the last 15 years, in comparison to previous studies. 10 For example the percentage of S. dysenteriae type 1 isolates resistant to ampicillin, tetracycline, cotrimoxazole, and amoxicillin was 90%, 86%, 91%, and 86% respectively, in contrast to the relatively low rate of resistance detected in 1985. At that time, Hassan 10 found that only 9% of Shigella species isolates were resistant to tetracycline, 20% to ampicillin, and 18% to cotrimoxazole. Again, resistance to chloramphenicol was increased in Shigella species in this study compared to the previous study by Hassan 10 when there was complete sensitivity.
Although the current study addressed a local problem in the Sudan, where it appears that there is a higher prevalence of antibiotic resistance compared to other countries, many other poor and developing countries are faced with a similar situation. 11 For instance, an increase in multiple drug resistance to S. dysenteriae type 1 has also been observed elsewhere. According to Bennis and others at the International Center for Diarrhoeal Disease Research in Bangladesh, 71.5% of isolates of S. dysenteriae type 1 were found to be resistant to ampicillin, 65.5% to cotrimoxazole, and 57.9% to nalidixic acid. 12 In 1979, an extensive epidemic in Zaire caused by S. dysenteriae type 1 resulted in high mortality. Rapid development of resistance to trimethoprim occurred within three months of beginning treatment. 13 Similar studies in other countries in east Africa showed similar patterns of resistance. In a diarrhea outbreak in northern Kenya, Shigella dysenteriae and Shigella flexneri were isolated that were sensitive only to nalidixic acid and furazolidine. 14 In yet another dysentery epidemic in Nairobi, Kenya, twentytwo genetically-related strains of S. dysenteriae type 1 were isolated and found to be resistant to ampicillin, trimethoprim, sulfamethoxazole, chloramphenicol, tetracycline, and streptomycin. 15 These few examples help to illustrate the extent of antibiotic resistance to Shigella dysenterae type 1 in developing countries. This organism is capable of causing large diarrheal outbreaks and epidemics resulting in high mortality, especially in children.
The high percentage of combined multiple-drug resistance observed in this study causes speculation that it may be determined by a common transferable factor, as was the case in two reports of antibiotic resistance in the Sudan. Shears and others 16 found that the resistance transfer pattern in Enterobacteriaceae among Sudanese children was most commonly mediated by plasmids. In a recent study of Escherichia coli isolated from patients with urinary tract infections in the Sudan, the most common resistance pattern-to ampicillin, tetracycline, and chloramphenicol, observed in 94%, 85%, and 54% of the isolates respectively-was found to be transferable by a plasmid. 17 It is important to observe that urinary P. mirabilis has a high rate of resistance to different antibiotics (Table 1a) . In modern clinical practice, amikacin is usually effective against the Enterobacteriaceae in general. That the high rate of resistance of P. mirabilis to various antibiotics is an unusual local phenomenon is supported by local clinical laboratory observations. Recent data has shown high levels of resistance of Enterobacteriaceae to amikacin (Hassan SH and others, unpublished data).
The overall prevalence of resistance of microorganisms to antimicrobial agents was notably high in the current study, similar to findings in previous studies, 10, 16 reflecting the high level of antibiotic resistance in the country as a whole, when compared to other countries. 11 Selection for drug resistance has been associated with an increased and inappropriate use of antibiotics. 18 There is an inordinate and irrational use of antimicrobial agents in the Sudan and in other developing countries. Multiple factors have led to the prevalence of antibiotic resistance: 1) the wide use of antibiotics due to the high prevalence of infectious diseases, 2) a shortage of physicians, 3) selective prescribing due to cost constraints and the pressure of pharmaceutical companies' promotional activities, 4) lack of laboratory support in rural areas, and 5) the difficulties in distributing information regarding antibiotic resistance. An important contributing factor in the Sudan is the deliberate self-administration of antibiotics by patients themselves when they are ill with diarrheal diseases. 19 Our findings stress the need for distributing reliable information about antibiotic resistance and for ongoing drug-resistance surveillance.
Knowledge of drug resistance in bacteria is indispensable for the proper selection of antimicrobial drugs. Sudan, a poor and underdeveloped country, allots a substantial amount of its health-expenditure allocation to the purchase of drugs, especially antibiotics. Resistance studies assist health authorities in the formulation of their own drug policies. They are also important for the general practitioner in a remote area who may not have access to microbiology laboratory back-up and hence must depend on the prevailing knowledge of antibiotic-resistant bacteria. Numerous health organizations world-wide donate large amounts of antibiotics to developing countries like the Sudan to treat diarrhea and other diseases at the community level. The composition of such donations should be based on current knowledge of the common local pathogenic bacteria and their susceptibility patterns.
